Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

Passage Bio Inc Is A Clinical-Stage Genetic Medicines Company Focused On Improving The Lives Of Patients With Neurodegenerative Diseases. Their Primary Focus Is The Development And Advancement Of Cutting-Edge, One-Time Gene Therapies Designed To Target Critical Underlying Pathologies In These Conditions. The Company Operates In A Single Reportable Segment, Developing And Advancing Genetic Medicines Designed To Target The Critical Underlying Pathology Of Neurodegenerative Diseases. The Pipeline Having Pbft02.